<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Biol</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Biol</journal-id><journal-title-group><journal-title>Pharmaceutical Biology</journal-title></journal-title-group><issn pub-type="ppub">1388-0209</issn><issn pub-type="epub">1744-5116</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7808742</article-id><article-id pub-id-type="pmid">33439064</article-id><article-id pub-id-type="doi">10.1080/13880209.2020.1866024</article-id><article-id pub-id-type="publisher-id">1866024</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>Sauropus brevipes</italic> ethanol extract negatively regulates inflammatory responses <italic>in&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic> by targeting Src, Syk and IRAK1</article-title><alt-title alt-title-type="left-running-head">J. H. Kim et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ji Hye</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="author-notes" rid="FN0001"/></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Jae Gwang</given-names></name><xref ref-type="aff" rid="AF0002">b</xref><xref ref-type="author-notes" rid="FN0001"/></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Yo Han</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="author-notes" rid="FN0001"/></contrib><contrib contrib-type="author"><name><surname>Shin</surname><given-names>Kon Kuk</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Jin Kyeong</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Young-Dong</given-names></name><xref ref-type="aff" rid="AF0003">c</xref></contrib><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>Ki Dong</given-names></name><xref ref-type="aff" rid="AF0004">d</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Kyung-Hee</given-names></name><xref ref-type="aff" rid="AF0005">e</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7937-0167</contrib-id><name><surname>Yoo</surname><given-names>Byong Chul</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1861-5543</contrib-id><name><surname>Sung</surname><given-names>Gi-Ho</given-names></name><xref ref-type="aff" rid="AF0006">f</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8141-9927</contrib-id><name><surname>Cho</surname><given-names>Jae Youl</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="corresp" rid="AN0002"/></contrib><aff id="AF0001"><label>a</label><institution>Department of Integrative Biotechnology and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University</institution>, <city>Suwon</city>, <country>Republic of Korea</country></aff><aff id="AF0002"><label>b</label><institution>Division of Translational Science, Research Institute, National Cancer Center</institution>, <city>Goyang</city>, <country>Republic of Korea</country></aff><aff id="AF0003"><label>c</label><institution>Department of Life Science, Hallym University</institution>, <city>Chuncheon</city>, <country>Republic of Korea</country></aff><aff id="AF0004"><label>d</label><institution>College of Pharmacy, The Catholic University of Korea</institution>, <city>Bucheon</city>, <country>Republic of Korea</country></aff><aff id="AF0005"><label>e</label><institution>Proteomic Analysis Team, Research Institute, National Cancer Center</institution>, <city>Goyang</city>, <country>Republic of Korea</country></aff><aff id="AF0006"><label>f</label><institution>Institute for Bio-Medical Convergence, International St. Mary&#x02019;s Hospital and College of Medicine, Catholic Kwandong University</institution>, <city>Incheon</city>, <country>Republic of Korea</country></aff></contrib-group><author-notes><fn id="FN0001"><label>*</label><p>These authors contributed equally to this work.</p></fn><corresp id="AN0001">CONTACT Gi-Ho Sung <email>sung97330@gmail.com</email><institution>Institute for Bio-Medical Convergence, International St. Mary&#x02019;s Hospital and College of Medicine, Catholic Kwandong University</institution>, <city>Incheon</city>, <country>Republic of Korea</country></corresp><corresp id="AN0002">Jae Youl Cho <email>jaecho@skku.edu</email><institution>Department of Integrative Biotechnology and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University</institution>, <city>Suwon</city>, <country>Republic of Korea</country>; Byong Chul Yoo <email>yoo_akh@hanmail.net</email><institution>Division of Translational Science, Research Institute, National Cancer Center</institution>, <city>Goyang</city>, <country>Republic of Korea</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>13</day><month>1</month><year>2021</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2021</year></pub-date><volume>59</volume><issue>1</issue><fpage seq="9">74</fpage><lpage>86</lpage><permissions><copyright-statement>&#x000a9; 2021 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IPHB_59_1866024.pdf"/><abstract><title>Abstract</title><sec><title>Context</title><p><italic>Sauropus brevipes</italic> M&#x000fc;ll. Arg. (Phyllanthaceae) has been used as an effective ingredient in a decoction for the treatment of diarrhoea. However, there was no report on its modulatory role in inflammation.</p></sec><sec><title>Objective</title><p>This study investigates anti-inflammatory effect of <italic>S. brevipes</italic> in various inflammation models.</p></sec><sec><title>Materials and methods</title><p>The aerial part of <italic>S. brevipes</italic> was extracted with 95% ethanol to produce Sb-EE. RAW264.7 cells pre-treated with Sb-EE were stimulated by lipopolysaccharide (LPS), and Griess assay and PCR were performed. High-performance liquid chromatography (HPLC) analysis, luciferase assay, Western blotting and kinase assay were employed. C57BL/6 mice (10 mice/group) were orally administered with Sb-EE (200&#x02009;mg/kg) once a day for five&#x000a0;days, and peritonitis was induced by an intraperitoneal injection of LPS (10&#x02009;mg/kg). ICR mice (four mice/group) were orally administered with Sb-EE (20 or 200&#x02009;mg/kg) or ranitidine (positive control) twice a day for two days, and EtOH/HCl was orally injected to induce gastritis.</p></sec><sec><title>Results</title><p>Sb-EE suppressed nitric oxide (NO) release (IC<sub>50</sub>=34&#x000a0;&#x000b5;g/mL) without cytotoxicity and contained flavonoids (quercetin, luteolin and kaempferol). Sb-EE (200&#x000a0;&#x000b5;g/mL) reduced the mRNA expression of inducible NO synthase (iNOS). Sb-EE blocked the activities of Syk and Src, while inhibiting interleukin-1 receptor associated kinases (IRAK1) by 68%. Similarly, orally administered Sb-EE (200&#x02009;mg/kg) suppressed NO production by 78% and phosphorylation of Src and Syk in peritonitis mice. Sb-EE also decreased inflammatory lesions in gastritis mice.</p></sec><sec><title>Discussion and conclusions</title><p>This study demonstrates the inhibitory effect of Sb-EE on the inflammatory response, suggesting that Sb-EE can be developed as a potential anti-inflammatory agent.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Natural product medicine</kwd><kwd>anti-inflammatory remedy</kwd><kwd>flavonoids</kwd><kwd>gastritis</kwd><kwd>peritonitis</kwd></kwd-group><counts><fig-count count="6"/><table-count count="1"/><page-count count="13"/><word-count count="8141"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001" disp-level="1"><title>Introduction</title><p>Inflammation, a non-specific response that is part of innate immunity, occurs as a protective response that does not depend on the type of pathogen or previous infection (Chen et&#x000a0;al. <xref rid="CIT0008" ref-type="bibr">2018</xref>). This response is initiated when pathogens are recognized by pathogen recognition receptors (PRRs). Pathogens such as bacteria, fungi and viruses interact with different PRRs, including Toll-like receptors (TLRs), retinoic acid-inducible gene-I-like receptors (RLRs), nucleotide-binding oligomerization domain-like receptors (NLRs) and C-type lectin receptors (CLRs) (Takeuchi and Akira <xref rid="CIT0054" ref-type="bibr">2010</xref>). Lipopolysaccharides (LPSs), a component of the cell wall in Gram negative bacteria, are recognized by TLR4, which resides on the surface of macrophages and transmits inflammatory signals inside the cells (Sabroe et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">2008</xref>). LPS-stimulated TLR4 recruits myeloid differentiation primary response 88 (MyD88) and TIR-domain-containing adapter-inducing interferon-&#x003b2; (TRIF), known as adaptor molecules, and activates nuclear factor-kappa B (NF-&#x003ba;B) and activator protein 1 (AP-1) by mediating phosphorylation-dependent signalling enzyme cascades (Akira and Takeda <xref rid="CIT0001" ref-type="bibr">2004</xref>; Kagan and Medzhitov <xref rid="CIT0022" ref-type="bibr">2006</xref>; Kagan et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2008</xref>; Tanimura et&#x000a0;al. <xref rid="CIT0055" ref-type="bibr">2008</xref>). In NF-&#x003ba;B activation, phosphorylation and degradation of inhibitor of nuclear factor kappa B (I&#x003ba;B&#x003b1;) are central steps, and this reaction is facilitated by activation of Src, Syk and p85 (Li et&#x000a0;al. <xref rid="CIT0036" ref-type="bibr">2003</xref>; Kawai and Akira <xref rid="CIT0025" ref-type="bibr">2007</xref>; Lee et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2007</xref>). Meanwhile, AP-1 signalling is mainly activated by sequential phosphorylation of signalling kinases such as interleukin-1 receptor associated kinases (IRAKs) and mitogen-activated protein kinases (MAPKs) such as extracellular-signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 (Janssens and Beyaert <xref rid="CIT0021" ref-type="bibr">2003</xref>). Then, the activated transcription factors (NF-&#x003ba;B and AP-1) modulate expression of cytokines and inflammatory genes, including inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and tumour necrosis factor-&#x003b1; (TNF-&#x003b1;), thereby treating infectious lesions or repairing tissue (Baeuerle and Henkel <xref rid="CIT0005" ref-type="bibr">1994</xref>; Liu et&#x000a0;al. <xref rid="CIT0040" ref-type="bibr">2018</xref>). However, excessive inflammation can cause tissue damage or chronic inflammatory diseases. Chronic inflammatory diseases such as ulcerative colitis, rheumatoid arthritis, lupus and Crohn&#x02019;s disease are painful and can adversely affect quality of life; they may also serve as the precursors to cardiovascular disease, diabetes and cancer (Roifman et&#x000a0;al. <xref rid="CIT0046" ref-type="bibr">2011</xref>; Schett et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2013</xref>). Therefore, after the danger signals such as pathogens and irritants are eliminated, post-inflammatory resolution is critical (Schett and Neurath <xref rid="CIT0050" ref-type="bibr">2018</xref>).</p><p>Previous drugs have targeted a single protein or enzyme, thereby reducing off-target effects and minimizing side effects. However, given the increasing evidence that chronic and intractable diseases &#x02013; including chronic inflammatory diseases, neurodegenerative diseases and cancer &#x02013; are caused by multiple genetic or environmental factors, the development of multi-target medications is accelerating (Medina-Franco et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2013</xref>; Kumar et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2018</xref>). In particular, ingredients extracted from natural products are in the spotlight in the multi-drug development field due to their therapeutic efficacy and safety, which has been proven by their longstanding usage as herbal medicines (Hoffmann <xref rid="CIT0017" ref-type="bibr">2013</xref>). For example, stillen was developed using ingredients from <italic>Artemisia asiatica</italic> Nakai (Asteraceae) extract and is currently on sale as an anti-inflammatory agent against gastritis (Park et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2008</xref>; Yoon et&#x000a0;al. <xref rid="CIT0062" ref-type="bibr">2011</xref>). Mevalotin, which is used for treatment of hyperlipidaemia, and tacrolimus, an immunosuppressive agent, are both medicines based on natural products (Calixto <xref rid="CIT0007" ref-type="bibr">2019</xref>). The natural product library is an interesting source for drug development, so continuous efficacy evaluation is required.</p><p>The genus <italic>Sauropus</italic> (Phyllanthaceae) consists of 40 species which are mainly distributed in Southeast Asia, Malaysia and Australia. Of these, <italic>S. androgynous</italic> L. Merr., which is an ingredient of Jamu, has traditionally been used for treating genito-urinary diseases, cardiovascular diseases and diabetes, as well as for enhancement of breast milk production and eyesight (Zhang et&#x000a0;al. <xref rid="CIT0064" ref-type="bibr">2020</xref>). Jamu is a traditional Indonesian medicine consisting of natural ingredients such as roots, bark, flowers, seeds, leaves and fruits (Woerdenbag and Kayser <xref rid="CIT0057" ref-type="bibr">2014</xref>). Leaves of <italic>S. androgynous</italic> contain phytochemicals such as polyphenols, anthocyanins, carotenoids, ascorbic acids and tannins (Singh et&#x000a0;al. <xref rid="CIT0052" ref-type="bibr">2011</xref>). In addition, <italic>S. androgynous</italic> has a high content of flavonoids including quercetin, kaempferol, myricetin, luteolin and apigenin (Arif <xref rid="CIT0003" ref-type="bibr">2020</xref>). It has been reported that ethanol, methanol or aqueous extracts of <italic>S. androgynus</italic> have anti-inflammatory, antimicrobial and antioxidant activities <italic>in&#x000a0;vitro</italic> (Eng Khoo et&#x000a0;al. <xref rid="CIT0012" ref-type="bibr">2015</xref>), and these pharmacological properties are thought to be due to bioactive phytochemicals. The anti-inflammatory properties of <italic>S. rostratus</italic> Miq. have also been reported (Zhen et&#x000a0;al. <xref rid="CIT0067" ref-type="bibr">2013</xref>). <italic>S. brevipes</italic> has been used to treat diarrhoea in a decoction, but no literature reports the pharmacological activity of this plant. Therefore, this study investigates the anti-inflammatory activity and mechanism of action of <italic>S. brevipes</italic> ethanol extract (Sb-EE) in LPS-stimulated RAW264.7 cells, LPS-induced peritonitis mice and HCl/EtOH-triggered gastritis mice.</p></sec><sec sec-type="materials" id="S0002" disp-level="1"><title>Materials and methods</title><sec id="S0002-S2001" disp-level="2"><title>Materials</title><p>The leaves and twigs of <italic>S. brevipes</italic> were collected at the Popa Mountain National Park (GPS location: 20&#x000b0;55&#x02032;N 95&#x000b0;15&#x02032;E), Mandalay Prov., Myanmar, in August 2013. Prof. Yong Dong Kim (Hallym University, Chuncheon, Korea) identified the plant. A voucher specimen (number: Cho S.H. et&#x000a0;al. MM408) was deposited in the herbariums of Hallym University (Chuncheon, Korea) and the National Institute of Biological Resources (Incheon, Korea). RAW264.7 cells and HEK293T cells were purchased from American Type Culture Collection (ATCC) (Rockville, MD). RPMI1640, DMEM, foetal bovine serum (FBS), phosphate-buffered saline (PBS) and penicillin&#x02013;streptomycin solution were purchased from Hyclone (Logan, UT). Lipopolysaccharide, 3-(4-5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide (MTT), DMSO, quercetin, luteolin, kaempferol, TRIzol, sodium dodecyl sulphate (SDS) and ranitidine were obtained from Sigma-Aldrich (St. Louis, MO). The cDNA synthesis kit was purchased from Thermo Fisher Scientific (Waltham, MA). Forward and reverse primers for iNOS, COX-2 and TNF-&#x003b1; were synthesized by Bioneer (Seoul, Korea). The kit for the luciferase assay was purchased from Promega (Madison, WI). Luciferase plasmids harbouring NF-&#x003ba;B or AP-1 binding promoter sites were used as reported previously (Yang et&#x000a0;al. <xref rid="CIT0060" ref-type="bibr">2014</xref>). Polyvinylidene fluoride (PVDF) membrane was purchased from Merck Millipore (Billerica, MA). Antibodies against c-Jun, c-Fos, p50, p65, lamin A/C, &#x003b2;-actin, IRAK1, IRAK-4 and phospho- and total forms of Src, Syk, p85, I&#x003ba;B&#x003b1;, ERK, JNK, p38, TAK1, MEK1/2, MKK4/7 and MKK3/6 were purchased from Cell Signaling Technology (Beverly, MA) and Santa Cruz Biotechnology (Santa Cruz, CA).</p></sec><sec id="S0002-S2002" disp-level="2"><title>Preparation of the Sb-EE</title><p>The leaves and twigs of <italic>S. brevipes</italic> were dried at room temperature and then cut and pulverized. The pulverized plant tissues (125&#x02009;g) were extracted with 95% ethanol (1500&#x02009;mL) in an ultrasonic bath, and the extract was evaporated to dryness under reduced pressure to produce a 95% ethanol extract of <italic>S. brevipes</italic> (Sb-EE) (3.7&#x02009;g). The Sb-EE powder was dissolved in DMSO at a concentration of 200&#x02009;mg/mL to make a stock solution. The experiment was performed using DMSO (vehicle) control at the same dilution as a negative control.</p></sec><sec id="S0002-S2003" disp-level="2"><title>Cell culture</title><p>To prepare cell culture media, 1% penicillin&#x02013;streptomycin was added to RPMI 1640 and DMEM supplemented with 10% FBS and 5% FBS, respectively. RAW264.7 and HEK293T cells were cultured using RPMI1640 and DMEM media in a humidified incubator maintained at 5% CO<sub>2</sub> and 37&#x02009;&#x000b0;C. Trypsin was used for the subculture of HEK293T cells, and a cell scraper was used to detach RAW264.7 cells from the plate.</p></sec><sec id="S0002-S2004" disp-level="2"><title>NO assay</title><p>RAW264.7 cells were pre-treated with Sb-EE (0, 25, 50, 100, 150 and 200&#x000a0;&#x000b5;g/mL) for 30&#x02009;min, then stimulated with LPS (1&#x000a0;&#x000b5;g/mL) for 24&#x02009;h. The supernatant (100&#x02009;&#x003bc;L) was mixed with 100&#x02009;&#x003bc;L of Griess reagent, as reported previously (Hossen et&#x000a0;al. <xref rid="CIT0020" ref-type="bibr">2017</xref>; Kim et&#x000a0;al. <xref rid="CIT0026" ref-type="bibr">2018</xref>). Griess reagent contains 0.2% naphthylethylenediamine dihydrochloride (NEDD) and 2% sulphanilamide in 5% phosphoric acid. The absorbance of this mixture was measured at 540&#x02009;nm and the concentration of nitric oxide (NO) was calculated by comparison with a standard curve.</p></sec><sec id="S0002-S2005" disp-level="2"><title>MTT assay</title><p>RAW264.7 cells and HEK293 cells were treated with Sb-EE at the indicated concentrations for 24&#x02009;h. Then, 10&#x02009;&#x003bc;L of MTT solution was added and incubated for 3&#x02009;h and the reaction was stopped using stopping solution (15% SDS), as reported previously (Hong et&#x000a0;al. <xref rid="CIT0018" ref-type="bibr">2018</xref>). The samples were then incubated overnight. The absorbance of MTT formazan was measured at a wavelength of 540&#x02009;nm.</p></sec><sec id="S0002-S2006" disp-level="2"><title>Animals</title><p>We purchased C57BL/6 mice for the peritonitis model and ICR mice for the gastritis model Biolink (Chungbuk, South Korea); 6&#x02013;8 mice per cage were housed in a 12&#x02009;h light/dark cycle. The care of animals was based on guidelines issued by the National Institute of Health for the Care and Use of Laboratory Animals (NIH Publication 80-23, revised in 1996). The study was conducted according to the guidelines established by the Institutional Animal Care and Use Committee (IACUC) at Sungkyunkwan University. The IACUC number was SKKUIACUC2018-10-16-1.</p></sec><sec id="S0002-S2007" disp-level="2"><title>High-performance liquid chromatography (HPLC) analysis</title><p>To characterize the phytochemical characteristic of Sb-EE, HPLC analysis was performed as described previously (Almela et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2006</xref>). Quercetin, luteolin and kaempferol were utilized as standard compounds. Solvent A (0.1% H<sub>3</sub>PO<sub>4</sub> in H<sub>2</sub>O) and solvent B (acetonitrile) were used as elution solvents. For analysis, a system equipped with a KNAUER (Wellchrom) HPLC-pump K-1001, a Wellchrom high-speed scanning spectrophotometer K-2600, and a four-channel deaerator K-500 and a Phenomenex Gemini C18 ODS (5&#x02009;&#x003bc;m) column was used.</p></sec><sec id="S0002-S2008" disp-level="2"><title>Semi-quantitative RT-PCR</title><p>RAW264.7 cells were pre-treated with Sb-EE for 30&#x02009;min and then stimulated by LPS (1&#x000a0;&#x000b5;g/mL) for 6&#x02009;h. Total RNA was isolated using TRIzol reagent according to the manufacturer&#x02019;s instructions. Semi-quantitative PCR was performed as reported previously (Baek et&#x000a0;al. <xref rid="CIT0004" ref-type="bibr">2016</xref>; Lee et&#x000a0;al. <xref rid="CIT0033" ref-type="bibr">2019</xref>). The sequences of primers used in this study are listed in <xref rid="t0001" ref-type="table">Table 1</xref>.</p><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Sequences of PCR primers used in this study.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th align="left">Targets</th><th align="center">Direction</th><th align="center">Sequences (5&#x02032; to 3&#x02032;)</th></tr></thead><tbody valign="top"><tr><td align="left">iNOS</td><td align="left">Forward</td><td align="left">GGAGCCTTTAGACCTCAACAGA</td></tr><tr><td align="left">&#x000a0;</td><td align="left">Reverse</td><td align="left">TGAACGAGGAGGGTGGTG</td></tr><tr><td align="left">COX-2</td><td align="left">Forward</td><td align="left">CACTACATCCTGACCCACTT</td></tr><tr><td align="left">&#x000a0;</td><td align="left">Reverse</td><td align="left">ATGCTCCTGCTTGAGTATGT</td></tr><tr><td align="left">TNF-&#x003b1;</td><td align="left">Forward</td><td align="left">GCCTCTTCTCATTCCTGCTTG</td></tr><tr><td align="left">&#x000a0;</td><td align="left">Reverse</td><td align="left">CTGATGAGAGGGAGGCCATT</td></tr><tr><td align="left">GAPDH</td><td align="left">Forward</td><td align="left">CAATGAATACGGCTACAGCAAC</td></tr><tr><td align="left">&#x000a0;</td><td align="left">Reverse</td><td align="left">AGGGAGATGCTCAGTGTTGG</td></tr></tbody></table></table-wrap></sec><sec id="S0002-S2009" disp-level="2"><title>Preparing whole or nuclear lysates</title><p>To obtain total cell lysate, harvested cells were first washed with cold PBS containing 1&#x02009;mM sodium orthovanadate. The washed cells were then lysed in ice-cold modified RIPA buffer (50&#x02009;mM Tris&#x02013;HCl, pH 7.4, 1% Nonidet P-40, 0.25% sodium deoxycholate, 150&#x02009;mM NaCl, 1&#x02009;mM Na<sub>3</sub>VO<sub>4</sub> and 1&#x02009;mM NaF) including protease inhibitors (2&#x02009;mM PMSF, 100&#x02009;&#x003bc;g/mL leupeptin, 10&#x02009;&#x003bc;g/mL pepstatin, 1&#x02009;&#x003bc;g/mL aprotinin and 2&#x02009;mM EDTA) for 30&#x02009;min with rotation at 4&#x02009;&#x000b0;C. At this time, a sonicator (Thermo Fisher Scientific, Waltham, MA) was used to improve cell lysis efficiency as reported previously (Choi et&#x000a0;al. <xref rid="CIT0009" ref-type="bibr">2019</xref>). Lysates were refined by centrifugation at 16,000&#x000d7;<italic>g</italic> for 10&#x02009;min at 4&#x02009;&#x000b0;C and stored at &#x02212;20&#x02009;&#x000b0;C until use. To prepare nuclear lysate, a three-step procedure was performed. In the first step, harvested cells were washed and lysed with 500&#x02009;mL lysis buffer (50&#x02009;mM KCl, 0.5% Nonidet P-40, 25&#x02009;mM HEPES, 1&#x02009;mM phenylmethylsulfonyl fluoride, 10&#x02009;&#x003bc;g/mL leupeptin, 20&#x02009;&#x003bc;g/mL aprotinin and 100&#x02009;&#x003bc;M 1,4-dithiothreitol) on ice for 4&#x02009;min. Second, lysates were centrifuged at 16,000&#x000d7;<italic>g</italic> for 1&#x02009;min. The pellet obtained from lysates was washed with washing buffer (lysis buffer without Nonidet P-40). Finally, the pellet containing nuclei was lysed with an extraction buffer (lysis buffer with 500&#x02009;mM KCl and 10% glycerol). The nuclei/extraction buffer mixture was frozen at &#x02212;80&#x02009;&#x000b0;C, and then centrifuged at 16,000&#x000d7;<italic>g</italic> for 5&#x02009;min. The supernatant was collected as a nuclear extract.</p></sec><sec id="S0002-S2010" disp-level="2"><title>Western blotting</title><p>Proteins in total cell lysates or nuclear fractions were separated with 7&#x02013;15% SDS-polyacrylamide gel electrophoresis (PAGE) (Choi et&#x000a0;al. <xref rid="CIT0009" ref-type="bibr">2019</xref>) and then transferred onto a PVDF membrane. To reduce non-specific antibody reactions, the PVDF membrane was first blocked with BSA. After washing twice with Tris-buffered saline including Tween 20 (TBST), the membrane was incubated overnight with primary antibody in BSA. After three washing steps with TBST, the membrane was probed with a secondary antibody conjugated with horseradish peroxidase in BSA for 1&#x02009;h. Immunoreactive bands were detected using an enhanced chemiluminescence kit (Pierce ECL Western blotting substrate, Thermo Scientific, Waltham, MA). Two different blots were obtained from two independent Western blotting analyses. Band intensity was measured and quantified using ImageJ (Bethesda, MD).</p></sec><sec id="S0002-S2011" disp-level="2"><title>Luciferase assay</title><p>HEK293T cells were transfected with plasmids harbouring a luciferase gene under an NF-&#x003ba;B promoter (NF-&#x003ba;B-Luc) or AP-1 promoter (AP-1-Luc). To activate the luciferase genes, MyD88 or TRIF genes were co-transfected. A beta-galactosidase (&#x003b2;-gal) reporter gene was also co-transfected as a control for normalization of transfection efficiency. Transfections were performed using the polyethylenimine (PEI) method as reported previously (Hossen et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2016</xref>; Han et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2018</xref>). The transfected cells were stabilized for 24&#x02009;h and then treated with Sb-EE for another 24&#x02009;h. Luciferase activity was measured with a luciferase assay system as described previously (Woo et&#x000a0;al. <xref rid="CIT0058" ref-type="bibr">2005</xref>).</p></sec><sec id="S0002-S2012" disp-level="2"><title><italic>In vitro</italic> kinase assay</title><p>A kinase profiler service from Millipore (Billerica, MA) was used to assess the direct inhibitory effect of Sb-EE against Src, Syk and IRAK1. An Sb-EE stock solution was prepared to 50&#x000d7; final assay concentration in 100% DMSO. The reaction was initiated by incubating with a Mg/ATP mixture. After 40&#x02009;min at room temperature, the reaction was stopped by adding 0.5% phosphoric acid. Then, 10&#x02009;&#x003bc;L of the reaction solution was spotted onto a P30 filtermat and washed four times for 4&#x02009;min in 0.425% phosphoric acid, followed by one wash in methanol. After this, the sample was dried and by scintillation counts.</p></sec><sec id="S0002-S2013" disp-level="2"><title>LPS-induced peritonitis <italic>in&#x000a0;vivo</italic> model</title><p>Acute peritonitis mice were generated using C57BL/6 mice (10 mice/group) as previously reported (Yi et&#x000a0;al. <xref rid="CIT0061" ref-type="bibr">2016</xref>). Sb-EE (200&#x02009;mg/kg) suspended in 0.5% sodium carboxymethylcellulose (CMC) was orally administered once per day for five&#x000a0;days. Acute peritonitis was induced with an intraperitoneal injection of 1.0&#x02009;mL (10&#x02009;mg/kg) LPS on day 4 after Sb-EE administration. Peritoneal fluid was harvested by intraperitoneal lavage using sterile PBS on day 5. In peritoneal macrophages obtained from peritonitis mice, NO production and phosphorylation pattern of target proteins were analysed using an NO assay and immunoblotting, respectively.</p></sec><sec id="S0002-S2014" disp-level="2"><title>HCl/EtOH-gastritis <italic>in&#x000a0;vivo</italic> model</title><p>To generate an acute gastritis mice model, ICR mice (four mice/group) were used as previously reported (Yang et&#x000a0;al. <xref rid="CIT0059" ref-type="bibr">2015</xref>). Sb-EE (200&#x02009;mg/kg) or ranitidine (40&#x02009;mg/kg) was orally injected into ICR mice twice a day for two days. After 1&#x02009;h of final administration, 60% ethanol in 150&#x02009;mM HCl was orally injected to induce gastritis. After 1&#x02009;h, mice were anaesthetized with isoflurane and sacrificed. Subsequently, redness of gastric mucosal lesions was observed.</p></sec><sec id="S0002-S2015" disp-level="2"><title>Statistical analysis</title><p>For the MTT and NO assays, two independent experiments were performed and each experimental group had 10 parallel wells to ensure the reliability of the results. In PCR, each experimental group was performed in triplicate using lysates obtained from three independent experiments. For Western blot analysis, two independent experiments were performed, and band intensity was measured and quantified using ImageJ (Bethesda, MD). Peritonitis and gastritis <italic>in&#x000a0;vivo</italic> experiments were performed with 10 or 4 mice per group, respectively. In this study, all data are presented as means&#x02009;&#x000b1;&#x02009;standard deviation (SD) obtained from each experiment. Analysis of variance (ANOVA) with Scheffe&#x02019;s <italic>post hoc</italic> test or the Kruskal&#x02013;Wallis/Mann&#x02013;Whitney tests was used to compare data and to assess the significance of group differences. A <italic>p</italic> value less than 0.05 indicates statistical significance.</p></sec></sec><sec sec-type="results" id="S0003" disp-level="1"><title>Results</title><sec id="S0003-S2001" disp-level="2"><title>Sb-EE inhibits NO production in LPS-stimulated RAW264.7 cells and contains flavonoids such as quercetin, luteolin and kaempferol</title><p>To evaluate the anti-inflammatory activity of Sb-EE, we assessed the effect of Sb-EE on NO production in LPS-stimulated RAW264.7 cells. In the Griess assay, Sb-EE (25, 50, 100, 150 and 200&#x000a0;&#x000b5;g/mL) significantly suppressed NO in a dose-dependent manner (IC<sub>50</sub>=34&#x000a0;&#x000b5;g/mL) (<xref ref-type="fig" rid="F0001">Figure 1(A)</xref>). On the other hand, MTT assay revealed that Sb-EE did not affect the viability of RAW264.7 and HEK 293 cells (<xref ref-type="fig" rid="F0001">Figure 1(B,C)</xref>), which indicates that suppressive effect of Sb-EE on NO production is not due to cytotoxicity. Then, HPLC analysis was performed to identify the phytochemical composition of Sb-EE. Quercetin, luteolin and kaempferol, which have strong antioxidant properties, were used as standard compounds (Crozier et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">2000</xref>; Romanova et&#x000a0;al. <xref rid="CIT0047" ref-type="bibr">2001</xref>; Zhang et&#x000a0;al. <xref rid="CIT0065" ref-type="bibr">2011</xref>). Peak of each standard compound was observed at certain retention time (quercetin = 34.2, luteolin = 35 and kaempferol = 39), and Sb-EE sample also has peaks at 34.2, 35 and 38.9&#x02009;min (<xref ref-type="fig" rid="F0001">Figure 1(D)</xref>). These results suggest that Sb-EE contained quercetin, luteolin and kaempferol, and that anti-inflammatory activity of Sb-EE may have been derived from these phenolic components.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Suppressive activity of Sb-EE against NO production in RAW264.7 cells. (A) To examine the effect of Sb-EE on NO release, Sb-EE pre-treated-RAW264.7 cells were stimulated with LPS (1&#x000a0;&#x000b5;g/mL) for 24&#x02009;h, and NO levels in supernatant were assessed by NO assay. (B, C) To test the cytotoxicity of Sb-EE, RAW264.7 cells (B) and HEK 293T cells (C) were dose-dependently treated with Sb-EE for 24&#x02009;h, and then MTT assay was performed. (D) Active phytochemical elements in Sb-EE were assessed by HPLC. The profiles of Sb-EE were compared with standard profiles containing quercetin, luteolin and kaempferol. All data are presented as the mean&#x02009;&#x000b1;&#x02009;SD of experiments. <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the normal group, and **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the LPS-alone treatment group. Rt (min) (area).</p></caption><graphic content-type="black-white" xlink:href="IPHB_A_1866024_F0001_B"/></fig></sec><sec id="S0003-S2002" disp-level="2"><title>Sb-EE suppresses expression of inflammatory genes and the activity of transcriptional factors NF-&#x003ba;B and AP-1</title><p>As NO production is mainly regulated by iNOS in macrophages, we evaluated the effect of Sb-EE on <italic>iNOS</italic> gene expression using semi-quantitative PCR (Lirk et&#x000a0;al. <xref rid="CIT0038" ref-type="bibr">2002</xref>). To further investigate the anti-inflammatory activity of Sb-EE, we examined the expression patterns of inflammatory genes such as <italic>COX-2</italic> and <italic>TNF-&#x003b1;</italic> in Sb-EE-pre-treated RAW264.7 cells. Sb-EE significantly diminished the mRNA expression of <italic>iNOS</italic> and <italic>COX-2</italic> at all concentrations (50, 100 and 200&#x000a0;&#x000b5;g/mL) in LPS-stimulated RAW264.7 cells (<xref ref-type="fig" rid="F0002">Figure 2(A)</xref>). TNF-&#x003b1; expression was also inhibited in the group pre-treated with 200&#x000a0;&#x000b5;g/mL Sb-EE (<xref ref-type="fig" rid="F0002">Figure 2(A)</xref>). Then, to understand the molecular mechanism underlying anti-inflammatory activity of Sb-EE, molecular biological assays were conducted using Sb-EE of 200&#x000a0;&#x000b5;g/mL, the most effective but non-cytotoxic concentration. As these genes are regulated at the transcriptional level, we studied whether Sb-EE regulates NF-&#x003ba;B and AP-1, which are major transcriptional factors in inflammatory gene expression (Liu et&#x000a0;al. <xref rid="CIT0040" ref-type="bibr">2018</xref>). A luciferase assay was performed using HEK 293 cells susceptible to plasmid transfection. To mimic LPS stimulation in RAW264.7 cells, HEK 293 cells were transfected with MyD88 or TRIF, which are adaptor proteins for TLR4 signalling (Akira and Takeda <xref rid="CIT0001" ref-type="bibr">2004</xref>). We found that Sb-EE blocked only MyD88-dependent NF-&#x003ba;B and AP-1 luc activity, not TRIF-dependent signalling (<xref ref-type="fig" rid="F0002">Figure 2(B,C)</xref>). The inhibitory activity of Sb-EE against NF-&#x003ba;B and AP-1 was further confirmed by immunoblotting with nuclear lysates. Consistent with our luciferase assay results, nuclear translocation of NF-&#x003ba;B subunits (p65 and p50) was significantly attenuated by Sb-EE at all indicated times after LPS stimulation (<xref ref-type="fig" rid="F0002">Figure 2(D)</xref>). Sb-EE also suppressed nuclear translocation of the AP-1 subunits, c-Fos and c-Jun, 30&#x02009;min after LPS stimulation (<xref ref-type="fig" rid="F0002">Figure 2(D)</xref>). These results indicate Sb-EE exerts its anti-inflammatory properties by inhibiting NF-&#x003ba;B and AP-1 signalling.</p><fig-group id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Effect of Sb-EE on inflammatory gene expression and transcriptional factors. (A) To verify the effect of Sb-EE on inflammatory biomarker expression, RAW264.7 cells were pre-treated with Sb-EE, then stimulated with LPS (1&#x000a0;&#x000b5;g/mL) for 6&#x02009;h. mRNA expression of <italic>iNOS</italic>, <italic>COX-2</italic> and <italic>TNF-&#x003b1;</italic> was analysed by semi-quantitative RT-PCR. (B, C) To validate the effect of Sb-EE on the transcriptional activity of NF-&#x003ba;B and AP-1, a luciferase assay was performed. HEK 293 cells were transfected with NF-&#x003ba;B-Luc (B) or AP-1-Luc (C) genes, and Flag-MyD88 or CFP-TRIF were additionally overexpressed to activate transcription of NF-&#x003ba;B-Luc and AP-1-Luc genes. Then, HEK 293 cells were treated with Sb-EE (0&#x02013;200&#x02009;&#x003bc;g/mL) for 24&#x02009;h. Luciferase activity was measured using a luminometer. (D) To analyse nuclear translocation of transcription factor subunits, Sb-EE (200&#x02009;&#x003bc;g/mL) pre-treated RAW264.7 cells were stimulated with LPS for the indicated times. Then, the levels of AP-1 (c-Fos and c-Jun) and NF-&#x003ba;B subunits (p65 and p50) in nuclear lysate were determined by immunoblotting. Lamin A/C was utilized as a loading control. All data are presented as the mean&#x02009;&#x000b1;&#x02009;SD of experiments. <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the normal group, and *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 and **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the control group (LPS-alone group in (A, D), and MyD88/TRIF-alone group in (B, C)).</p></caption><fig id="F0002a" fig-type="figure" orientation="portrait" position="anchor"><graphic content-type="black-white" xlink:href="IPHB_A_1866024_F0002a_B"/></fig><fig id="F0002b" fig-type="figure" orientation="portrait" position="anchor"><graphic content-type="black-white" xlink:href="IPHB_A_1866024_F0002b_B"/></fig></fig-group></sec><sec id="S0003-S2003" disp-level="2"><title>Sb-EE diminished NF-&#x003ba;B signalling by targeting Src and Syk kinases</title><p>To understand the molecular mechanism by which Sb-EE regulates the inflammatory response, we examined the alteration in NF-&#x003ba;B signalling enzymes including I&#x003ba;B&#x003b1;, p85, Syk and Src. The phosphorylation levels of each signal molecule were evaluated by immunoblotting in LPS-stimulated RAW264.7 cells after Sb-EE pre-treatment. Sb-EE suppressed p-I&#x003ba;B&#x003b1; levels at all LPS-stimulated time points (5, 15, 30 and 60&#x02009;min) (<xref ref-type="fig" rid="F0003">Figure 3(A)</xref>). Phosphorylation patterns of upstream molecules of I&#x003ba;B&#x003b1; such as p85, Syk and Src were checked at the earlier time than 5&#x02009;min. As shown in <xref ref-type="fig" rid="F0003">Figure 3(B)</xref>, p-Syk and p-p85 were inhibited by Sb-EE at 3&#x02009;min and 5&#x02009;min after LPS activation. Phosphorylation of Src kinase was also diminished by Sb-EE after 1&#x02009;min and 3&#x02009;min of LPS stimulation (<xref ref-type="fig" rid="F0003">Figure 3(B)</xref>). Total Src, Syk and p85 were not affected by Sb-EE (<xref ref-type="fig" rid="F0003">Figure 3(B)</xref>). Since Src and Syk are the most upstream enzymes in TLR4-mediated NF-&#x003ba;B signalling, we hypothesized that Sb-EE would directly regulate Src and Syk (Lowell <xref rid="CIT0041" ref-type="bibr">2011</xref>) and performed an <italic>in&#x000a0;vitro</italic> kinase assay for Src and Syk kinase to test this. As we expected, Sb-EE reduced Src and Syk kinase activity down to basal levels (<xref ref-type="fig" rid="F0003">Figure 3(C,D)</xref>). These results imply that Sb-EE directly inhibits Src and Syk kinases to suppress NF-&#x003ba;B signalling.</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Inhibitory effect of Sb-EE on NF-&#x003ba;B signalling enzymes. (A, B) RAW264.7 cells were treated with LPS (1&#x000a0;&#x000b5;g/mL) for the indicated time in the presence or absence of Sb-EE (200&#x02009;&#x003bc;g/mL). The levels of phospho- and total-I&#x003ba;B&#x003b1; (A), Src, Syk, p85 and &#x003b2;-actin (B) were determined by immunoblotting using whole lysates. (C) RAW264.7 cells were pre-treated with Sb-EE in a dose-dependent manner, and were thereafter triggered with LPS for 3&#x02009;min. Then, p-Src, Src and &#x003b2;-actin levels were detected by immunoblotting. (D) To examine the direct effects of Sb-EE on Src and Syk activity, an <italic>in&#x000a0;vitro</italic> kinase assay was performed with purified Src and Syk. <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the normal group, and *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 and **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the control group (LPS alone group in (A&#x02013;C)).</p></caption><graphic content-type="black-white" xlink:href="IPHB_A_1866024_F0003_B"/></fig></sec><sec id="S0003-S2004" disp-level="2"><title>Sb-EE attenuates AP-1 signalling by targeting IRAK1</title><p>Since Sb-EE suppressed AP-1 luc activity and nuclear translocation of the AP-1 subunit, we explored the effects of Sb-EE on AP-1 signalling regulators, such as ERK, JNK and p38 (<xref ref-type="fig" rid="F0002">Figure 2(C,D)</xref>). To identify the target of Sb-EE among the signalling molecules passing through the AP-1 pathway, we stimulated Sb-EE-pre-treated RAW264.7 cells with LPS for various times. Immunoblotting analysis revealed that phosphorylation of ERK is blocked by Sb-EE after 30&#x02009;min of LPS simulation (<xref ref-type="fig" rid="F0004">Figure 4(A)</xref>). Sb-EE also inhibited phosphorylation of JNK and p38 five min after LPS treatment without changing the total levels of each enzyme (<xref ref-type="fig" rid="F0004">Figure 4(A)</xref>). Phosphorylated MEK1/2, an upstream regulator of ERK, was inhibited by Sb-EE at 15 and 30&#x02009;min after LPS stimulation. In the case of MKK4/7, a JNK regulator, and MKK3/6, a p38 activator, phosphorylation was suppressed 5&#x02009;min after the LPS trigger (<xref ref-type="fig" rid="F0004">Figure 4(B)</xref>, left and right panel). As TAK1 is an indispensable kinase that activates MKK4/7 and MKK3/6 in the TLR-AP-1 signal pathway (Kishimoto et&#x000a0;al. <xref rid="CIT0028" ref-type="bibr">2000</xref>), we evaluated whether Sb-EE controls TAK1. Sb-EE blocked p-TAK1 levels at all indicated time points (5, 15, 30 and 60&#x02009;min) in LPS-triggered RAW264.7 cells (<xref ref-type="fig" rid="F0004">Figure 4(B)</xref>, left and right panel). We further assessed modulation of IRAK1/4, the most upstream regulators of the TLR4-dependent AP-1 pathway (Gan and Li <xref rid="CIT0014" ref-type="bibr">2006</xref>). Interestingly, LPS-induced degradation of IRAK1 was restored by Sb-EE at 3&#x02009;min, which suggests that IRAK1 might be a target of Sb-EE (<xref ref-type="fig" rid="F0004">Figure 4(C)</xref>). Our hypothesis was verified by <italic>in&#x000a0;vitro</italic> kinase assay. As we expected, Sb-EE decreased the kinase activity of IRAK1 by 68% (<xref ref-type="fig" rid="F0004">Figure 4(D)</xref>). These results indicate that Sb-EE directly inhibits IRAK1, leading to an anti-inflammatory response.</p><fig-group id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Inhibitory effect of Sb-EE on AP-1 signalling enzymes. (A&#x02013;C) RAW264.7 cells were treated with LPS (1&#x000a0;&#x000b5;g/mL) for the indicated time in the presence or absence of Sb-EE (200&#x02009;&#x003bc;g/mL). Then, an immunoblotting assay was performed with antibodies for phospho- and total-forms of target proteins. The antibodies against p-ERK, ERK, p-JNK, JNK, p-p85 and p85 antibodies were used to detect the MAPKs (A). The antibodies against p-TAK1, TAK-1, p-MEK1/2, MEK1/2, p-MKK4/7, MKK4/7, p-MKK3/6 and MKK3/6 were used to detect the upstream enzymes of MAPKs (B, left and right panel). IRAK-1 and IRAK-4 antibodies were used to detect the initially activated enzymes in the AP-1 signalling pathway (C). (D) To examine the direct effects of Sb-EE on IRAK1 activity, an <italic>in&#x000a0;vitro</italic> kinase assay was performed with purified IRAK1. <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the normal group, *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 and **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the control group (LPS-alone group in (A), (B, left and right panel) and (C)).</p></caption><fig id="F0004a" fig-type="figure" orientation="portrait" position="anchor"><graphic content-type="black-white" xlink:href="IPHB_A_1866024_F0004a_B"/></fig><fig id="F0004b" fig-type="figure" orientation="portrait" position="anchor"><graphic content-type="black-white" xlink:href="IPHB_A_1866024_F0004b_B"/></fig></fig-group></sec><sec id="S0003-S2005" disp-level="2"><title>Sb-EE alleviates LPS-induced peritonitis and HCl/EtOH-stimulated gastritis in mice</title><p>We further evaluated the anti-inflammatory activity of Sb-EE in <italic>in&#x000a0;vivo</italic> peritonitis and gastritis mouse models. Peritonitis was induced by intraperitoneal injection of 10&#x02009;mg/kg LPS after oral administration of Sb-EE for five&#x000a0;days. To assess the inhibitory effect of Sb-EE against peritonitis, we performed an NO assay and immunoblotting analysis with macrophages obtained from the peritoneums of peritonitis-induced mice. The NO assay showed that Sb-EE (200&#x02009;mg/kg) suppresses NO production in peritonitis mice (<xref ref-type="fig" rid="F0005">Figure 5(A)</xref>). In addition, immunoblotting with lysates of peritoneal macrophages revealed that Sb-EE inhibited phosphorylation of ERK, p38, Src and Syk (<xref ref-type="fig" rid="F0005">Figure 5(B)</xref>), which is consistent with our <italic>in&#x000a0;vitro</italic> results. Next, we induced gastritis in mice by oral administration of HCl/EtOH for 1&#x02009;h after orally injecting Sb-EE or ranitidine, a positive control, three times at 12&#x02009;h intervals. We then observed haemorrhagic mucosal damage to determine the degree of gastric mucosal inflammation. Bleeding and redness of the gastric mucosa was reduced in both the ranitidine and Sb-EE-treated groups (<xref ref-type="fig" rid="F0005">Figure 5(C)</xref>). These results indicate that Sb-EE is effective in the treatment of inflammatory diseases including peritonitis and gastritis.</p><fig id="F0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Anti-inflammatory ability of Sb-EE in LPS-induced peritonitis and HCl/EtOH-triggered gastritis mice. (A, B) Sb-EE (200&#x02009;mg/kg) was orally injected into C57BL/6 mice daily for five&#x000a0;days. Peritonitis was induced by peritoneal injection of LPS (10&#x000a0;&#x000b5;g/kg) for one&#x000a0;day. NO assay was performed using peritoneal macrophages (A). Immunoblotting assay was performed with whole lysates obtained from peritoneal exudates. Phospho- or total-forms of ERK, p38, Src, Syk and &#x003b2;-actin were detected using specific antibodies (B). (C) Sb-EE (200&#x02009;mg/kg) or ranitidine (40&#x02009;mg/kg) was orally administered in ICR mice twice a day for two days, and then HCl/EtOH was injected for 1&#x02009;h to induce gastritis. Stomach inflammatory lesions were photographed with a digital camera and then quantified using ImageJ. <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the normal group, *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 and **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 compared to the control group (LPS-alone group in (A, B), and HCl/EtOH alone group in (C)).</p></caption><graphic content-type="color" xlink:href="IPHB_A_1866024_F0005_C"/></fig></sec></sec><sec sec-type="discussion" id="S0004" disp-level="1"><title>Discussion</title><p>The ethanolic extract of <italic>S. androgynous</italic> has been reported to exert anti-inflammatory activity against carrageenan induced rat paw oedema at dose of 400&#x02009;mg/kg/body weight (Selvi and Anusha <xref rid="CIT0051" ref-type="bibr">2012</xref>). The anti-inflammatory property of this herb was also proved <italic>in&#x000a0;vitro</italic> experiment using RAW 264.7 cells (Lee et&#x000a0;al. <xref rid="CIT0034" ref-type="bibr">2011</xref>). In the case of <italic>S. rostratus</italic>, water extract of the root shows anti-inflammatory effect on dimethylbenzene-induced auricle oedema mice (Zhen et&#x000a0;al. <xref rid="CIT0067" ref-type="bibr">2013</xref>). In this study, we evaluated the pharmaceutical effects of the ethanolic extract of <italic>S. brevipes in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic>. As shown in <xref ref-type="fig" rid="F0001">Figure 1(A,B)</xref>, Sb-EE significantly reduced NO release without cytotoxicity. As NO is a key inflammatory mediator and various anti-inflammatory drugs including NSAIDs target NO synthesis and secretion (Stratman et&#x000a0;al. 1997; Di Girolamo et&#x000a0;al. <xref rid="CIT0011" ref-type="bibr">2003</xref>), Sb-EE was also expected to have potent therapeutic efficacy in inflammatory diseases. PCR results showing the inhibitory effects of Sb-EE on inflammatory gene expression of <italic>iNOS</italic>, <italic>COX-2</italic> and <italic>TNF-&#x003b1;</italic> also supported our hypothesis (<xref ref-type="fig" rid="F0002">Figure 2(A)</xref>). Therefore, we decided to validate the therapeutic effect of Sb-EE on inflammatory diseases using <italic>in&#x000a0;vivo</italic> models such as LPS-induced peritonitis mice and HCl/EtOH-triggered gastritis mice. Consistent with RAW264.7 cell results, oral administration of Sb-EE (200&#x02009;mg/kg) strongly inhibited NO levels in peritoneal macrophages from peritonitis mice (<xref ref-type="fig" rid="F0005">Figure 5(A)</xref>). Sb-EE also alleviated gastritis symptoms, which suggests that it can be used as treatment for inflammatory diseases.</p><p>Flavonoids are natural substances with a phenolic structure, and widely distributed in plants (Galeotti et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2008</xref>; Higdon et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2017</xref>). They exhibit the biological activities such as anticancer, anti-inflammatory and antiviral, which are based on their antioxidant properties (Wei et&#x000a0;al. <xref rid="CIT0056" ref-type="bibr">2011</xref>; Zhen et&#x000a0;al. <xref rid="CIT0067" ref-type="bibr">2013</xref>; Madhu et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2014</xref>; Zhang et&#x000a0;al. <xref rid="CIT0066" ref-type="bibr">2017</xref>; Kuttinath and Rammohan <xref rid="CIT0031" ref-type="bibr">2019</xref>). Flavonoids are classified into five subtypes according to their structure. Of them, flavones and flavonols with C-2,3-double bonds have been reported to show strong inhibition of NO production (Kim et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2004</xref>). Since anti-inflammatory activity of flavonoids is primarily due to their scavenging effect on NO (Nijveldt et&#x000a0;al. <xref rid="CIT0044" ref-type="bibr">2001</xref>), it was investigated whether Sb-EE contained luteolin, kaempferol and quercetin which are representative flavonones and flavonols. HPLC analysis revealed that Sb-EE contains these standard flavonoids (<xref ref-type="fig" rid="F0001">Figure 1(D)</xref>). In addition, Sb-EE inhibited the gene expression of <italic>iNOS</italic> (<xref ref-type="fig" rid="F0002">Figure 2(A)</xref>), similar to the results of previous studies that the mechanism of NO inhibition of flavonones and flavonols is dependent to iNOS down-regulation, not to iNOS activity (Kim et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2004</xref>). This suggests that luteolin, quercetin and kaempferol are the active ingredients of Sb-EE. Furthermore, as several high peaks were observed at retention time of 20&#x02013;30&#x02009;min (<xref ref-type="fig" rid="F0001">Figure 1(D)</xref>), it is expected that a large number of phytochemicals other than luteolin, kaempferol and quercetin might be contained in Sb-EE. Plants belonging to the genus <italic>Sauropus</italic> have a high content of apigenin which is a powerful NO inhibitor and a natural flavonoid (Bunawan et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2015</xref>). Therefore, Sb-EE is also expected to contain apigenin, and eventually these flavonoids are expected to synergistically reduce the NO production and to exhibit anti-inflammatory action.</p><p>To understand the intracellular mechanism of Sb-EE, we examined alterations in the TLR4 signalling pathway during Sb-EE treatment. Since <xref ref-type="fig" rid="F0002">Figure 2(A)</xref> shows a defect in the mRNA expression of inflammatory genes, we confirmed these changes in transcriptional factors. Sb-EE blocked both NF-&#x003ba;B and AP-1 activity (<xref ref-type="fig" rid="F0002">Figure 2(B&#x02013;D)</xref>), and also suppressed phosphorylation of upstream enzymes responsible for activating NF-&#x003ba;B and AP-1 signalling such as I&#x003ba;B&#x003b1;, p85, ERK, JNK, p38, TAK1, MEK1/2, MKK4/7 and MKK3/6 (<xref ref-type="fig" rid="F0003">Figures 3(A,B)</xref> and <xref ref-type="fig" rid="F0004">4(A,B)</xref>, left and right panel). In TLR4 signalling, external stimuli activate NF-&#x003ba;B and AP-1 through recruitment of the adapter molecules MyD88 and TRIF (Akira and Takeda <xref rid="CIT0001" ref-type="bibr">2004</xref>). Interestingly, Sb-EE affects only MyD88-activated NF-&#x003ba;B and AP-1 luciferase activities, not TRIF-triggered signalling (<xref ref-type="fig" rid="F0002">Figure 2(B,C)</xref>), which suggests that the MyD88-dependent pathway is a target of Sb-EE. According to immunoblotting and <italic>in&#x000a0;vitro</italic> kinase assays, Sb-EE directly inhibited Syk, Src and IRAK1 kinases, which are activated first in response to PAMPs (<xref ref-type="fig" rid="F0003">Figures 3(B,D)</xref> and <xref ref-type="fig" rid="F0004">4(C,D)</xref>) (Kawagoe et&#x000a0;al. <xref rid="CIT0024" ref-type="bibr">2008</xref>; Lowell <xref rid="CIT0041" ref-type="bibr">2011</xref>). As TLR4 transduces MyD88 signals via IRAK4/1 to activate AP-1 (Li et&#x000a0;al. <xref rid="CIT0035" ref-type="bibr">2002</xref>), inhibition of IRAK1 by Sb-EE correlates with luciferase assay results. On the other hand, the role of Syk and Src kinase is more complicated in intracellular TLR signalling. In the classic TLR4 pathway, Src and Syk tend to be activated first and function together in response to LPS engagement (Lowell <xref rid="CIT0041" ref-type="bibr">2011</xref>). Then, they can activate MyD88 and TRIF signals through different pathways. For example, Src kinase can activate a MyD88 dependent pathway via TRAF6 (Liu et&#x000a0;al. <xref rid="CIT0039" ref-type="bibr">2012</xref>). On the other hand, there is also report demonstrating that Src is involved in TRIF-mediated IFN-&#x003b2; production (Li et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2017</xref>). Syk also promotes internalization of TLR4 by phosphorylation of ITAM motif-containing proteins such as DAP12 and Fc&#x003b5;RI&#x003b3;, thereby activating TRIF-mediated interferon production (Zanoni et&#x000a0;al. <xref rid="CIT0063" ref-type="bibr">2011</xref>). As the role of Syk in TRIF signalling is limited to regulating interferon-regulatory factor (IRF), not NF-&#x003ba;B and AP-1, Sb-EE seems to show selectivity for the MyD88-pathway in terms of NF-&#x003ba;B and AP-1 regulation.</p></sec><sec sec-type="conclusions" id="S0005" disp-level="1"><title>Conclusions</title><p>Sb-EE suppressed NO production in RAW264.7 cells and attenuated inflammatory symptoms in LPS-induced peritonitis and HCl/EtOH-triggered gastritis mice, which suggest Sb-EE has anti-inflammatory activity. Sb-EE inhibited phosphorylation of LPS-triggered signal molecules, such as p85, I&#x003ba;B&#x003b1;, TAK1, MEK1/2, MKK4/7, MKK3/6, ERK, JNK and p38. In particular, Sb-EE acts as a direct inhibitor of Src, Syk and IRAK1, thereby inhibiting MyD88-dependent NF-<italic>&#x003ba;</italic>B and AP-1. As a result, Sb-EE blocked mRNA expression of <italic>iNOS</italic>, <italic>COX-2</italic> and <italic>TNF-&#x003b1;</italic>, which play critical role in inflammation (<xref ref-type="fig" rid="F0006">Figure 6</xref>). The paradigm of drug development is changing from single-target to multi-target drugs with the increase in chronic and intractable diseases. Therefore, drug development derived from natural products capable of interacting with various proteins in a biological system is accelerating (Koeberle and Werz <xref rid="CIT0029" ref-type="bibr">2014</xref>). In this respect, it is expected that Sb-EE derived from edible herbs can be used to develop a potent anti-inflammatory agent.</p><fig id="F0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Schematic diagram of the anti-inflammatory properties of Sb-EE through inhibition of AP-1 and NF-&#x003ba;B signalling.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1866024_F0006_C"/></fig></sec></body><back><sec id="S0006" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>The authors declare no conflict of interest.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>K.</given-names></name></person-group>
<year>2004</year>
<article-title>Toll-like receptor signalling</article-title>. <source>Nat Rev Immunol</source>. <volume>4</volume>(<issue>7</issue>):<fpage>499</fpage>&#x02013;<lpage>511</lpage>.<pub-id pub-id-type="pmid">15229469</pub-id></mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almela</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sanchez-Munoz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Fernandez-Lopez</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Roca</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Rabe</surname><given-names>V.</given-names></name></person-group>
<year>2006</year>
<article-title>Liquid chromatographic&#x02013;mass spectrometric analysis of phenolics and free radical scavenging activity of rosemary extract from different raw material</article-title>. <source>J Chromatogr A</source>. <volume>1120</volume>(<issue>1&#x02013;2</issue>):<fpage>221</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">16563403</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arif</surname><given-names>T.</given-names></name></person-group>
<year>2020</year>
<article-title>Therapeutic potential and traditional uses of <italic>Sauropus androgynous</italic>: a review</article-title>. <source>J Pharmacogn Phytochem</source>. <volume>9</volume>:<fpage>2131</fpage>&#x02013;<lpage>2137</lpage>.</mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baek</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Son</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>NY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aravinthan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JY.</given-names></name></person-group>
<year>2016</year>
<article-title>In vitro and in&#x000a0;vivo anti-inflammatory activities of Korean Red Ginseng-derived components</article-title>. <source>J Ginseng Res</source>. <volume>40</volume>(<issue>4</issue>):<fpage>437</fpage>&#x02013;<lpage>444</lpage>.<pub-id pub-id-type="pmid">27746698</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baeuerle</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Henkel</surname><given-names>T.</given-names></name></person-group>
<year>1994</year>
<article-title>Function and activation of NF-kappa B in the immune system</article-title>. <source>Annu Rev Immunol</source>. <volume>12</volume>:<fpage>141</fpage>&#x02013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">8011280</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunawan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bunawan</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Baharum</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Noor</surname><given-names>NM.</given-names></name></person-group>
<year>2015</year>
<article-title><italic>Sauropus androgynus</italic> (L.) Merr. induced bronchiolitis obliterans: from botanical studies to toxicology</article-title>. <source>Evid Based Complement Alternat Med</source>. <volume>2015</volume>:<fpage>714158</fpage>.<pub-id pub-id-type="pmid">26413127</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calixto</surname><given-names>JB.</given-names></name></person-group>
<year>2019</year>
<article-title>The role of natural products in modern drug discovery</article-title>. <source>An Acad Bras Cienc</source>. <volume>91</volume>(<issue>Suppl. 3</issue>):<fpage>e20190105</fpage>.<pub-id pub-id-type="pmid">31166478</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zuo</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name></person-group>
<year>2018</year>
<article-title>Inflammatory responses and inflammation-associated diseases in organs</article-title>. <source>Oncotarget</source>. <volume>9</volume>(<issue>6</issue>):<fpage>7204</fpage>&#x02013;<lpage>7218</lpage>.<pub-id pub-id-type="pmid">29467962</pub-id></mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JY.</given-names></name></person-group>
<year>2019</year>
<article-title>AKT1-targeted proapoptotic activity of compound K in human breast cancer cells</article-title>. <source>J Ginseng Res</source>. <volume>43</volume>(<issue>4</issue>):<fpage>692</fpage>&#x02013;<lpage>698</lpage>.<pub-id pub-id-type="pmid">31695573</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crozier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Burns</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aziz</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Rabiasz</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>GI</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Lean</surname><given-names>ME.</given-names></name></person-group>
<year>2000</year>
<article-title>Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability</article-title>. <source>Biol Res</source>. <volume>33</volume>(<issue>2</issue>):<fpage>79</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">15693274</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Girolamo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Farina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Riberio</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Ogando</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Aisemberg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>de los Santos</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Marti</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Franchi</surname><given-names>AM.</given-names></name></person-group>
<year>2003</year>
<article-title>Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum</article-title>. <source>Br J Pharmacol</source>. <volume>139</volume>(<issue>6</issue>):<fpage>1164</fpage>&#x02013;<lpage>1170</lpage>.<pub-id pub-id-type="pmid">12871835</pub-id></mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khoo</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Azlan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ismaila</surname><given-names>A.</given-names></name></person-group>
<year>2015</year>
<article-title><italic>Sauropus androgynus</italic> leaves for health benefits: hype and the science</article-title>. <source>Nat Prod J</source>. <volume>5</volume>(<issue>2</issue>):<fpage>115</fpage>&#x02013;<lpage>123</lpage>.</mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galeotti</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Barile</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Curir</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dolci</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lanzotti</surname><given-names>V.</given-names></name></person-group>
<year>2008</year>
<article-title>Flavonoids from carnation (<italic>Dianthus caryophyllus</italic>) and their antifungal activity</article-title>. <source>Phytochem Lett</source>. <volume>1</volume>(<issue>1</issue>):<fpage>44</fpage>&#x02013;<lpage>48</lpage>.</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L.</given-names></name></person-group>
<year>2006</year>
<article-title>Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity</article-title>. <source>Immunol Res</source>. <volume>35</volume>(<issue>3</issue>):<fpage>295</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="pmid">17172653</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Seo</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JY.</given-names></name></person-group>
<year>2018</year>
<article-title>AKT-targeted anti-inflammatory activity of <italic>Panax ginseng</italic> calyx ethanolic extract</article-title>. <source>J Ginseng Res</source>. <volume>42</volume>(<issue>4</issue>):<fpage>496</fpage>&#x02013;<lpage>503</lpage>.<pub-id pub-id-type="pmid">30337810</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Higdon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Drake</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Delage</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Crozier</surname><given-names>A.</given-names></name></person-group>
<year>2017</year> Flavonoids. Corvallis (OR): Linus Pauling Institute, Oregon State University. <ext-link ext-link-type="uri" xlink:href="https://lpi.oregonstate.edu/mic/dietary-factors/phytochemicals/flavonoids">https://lpi.oregonstate.edu/mic/dietary-factors/phytochemicals/flavonoids</ext-link>.</mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffmann</surname><given-names>RW.</given-names></name></person-group>
<year>2013</year>
<article-title>Natural product synthesis: changes over time</article-title>. <source>Angew Chem Int Ed Engl</source>. <volume>52</volume>(<issue>1</issue>):<fpage>123</fpage>&#x02013;<lpage>130</lpage>.<pub-id pub-id-type="pmid">23203402</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nam</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>S-G</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2018</year>
<article-title>Photoaging protective effects of BIOGF1K, a compound-K-rich fraction prepared from <italic>Panax ginseng</italic></article-title>. <source>J Ginseng Res</source>. <volume>42</volume>(<issue>1</issue>):<fpage>81</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">29348726</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hossen</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JY.</given-names></name></person-group>
<year>2016</year>
<article-title>MAPK/AP-1-targeted anti-inflammatory activities of <italic>Xanthium strumarium</italic></article-title>. <source>Am J Chin Med</source>. <volume>44</volume>(<issue>6</issue>):<fpage>1111</fpage>&#x02013;<lpage>1125</lpage>.<pub-id pub-id-type="pmid">27627914</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hossen</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Aravinthan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JY.</given-names></name></person-group>
<year>2017</year>
<article-title>Thymoquinone: an IRAK1 inhibitor with i<italic>n vivo</italic> and <italic>in&#x000a0;vitro</italic> anti-inflammatory activities</article-title>. <source>Sci Rep</source>. <volume>7</volume>:<fpage>42995</fpage>.<pub-id pub-id-type="pmid">28216638</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janssens</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Beyaert</surname><given-names>R.</given-names></name></person-group>
<year>2003</year>
<article-title>Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members</article-title>. <source>Mol Cell</source>. <volume>11</volume>(<issue>2</issue>):<fpage>293</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="pmid">12620219</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kagan</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group>
<year>2006</year>
<article-title>Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling</article-title>. <source>Cell</source>. <volume>125</volume>(<issue>5</issue>):<fpage>943</fpage>&#x02013;<lpage>955</lpage>.<pub-id pub-id-type="pmid">16751103</pub-id></mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kagan</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Horng</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group>
<year>2008</year>
<article-title>TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta</article-title>. <source>Nat Immunol</source>. <volume>9</volume>(<issue>4</issue>):<fpage>361</fpage>&#x02013;<lpage>368</lpage>.<pub-id pub-id-type="pmid">18297073</pub-id></mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawagoe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Matsushita</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Matsui</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kumagai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Saitoh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kawai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Takeuchi</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group>
<year>2008</year>
<article-title>Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2</article-title>. <source>Nat Immunol</source>. <volume>9</volume>(<issue>6</issue>):<fpage>684</fpage>&#x02013;<lpage>691</lpage>.<pub-id pub-id-type="pmid">18438411</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group>
<year>2007</year>
<article-title>Signaling to NF-kappaB by Toll-like receptors</article-title>. <source>Trends Mol Med</source>. <volume>13</volume>(<issue>11</issue>):<fpage>460</fpage>&#x02013;<lpage>469</lpage>.<pub-id pub-id-type="pmid">18029230</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Son</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Nam</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hossain</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JY.</given-names></name></person-group>
<year>2018</year>
<article-title>BIOGF1K, a compound K-rich fraction of ginseng, plays an antiinflammatory role by targeting an activator protein-1 signaling pathway in RAW264.7 macrophage-like cells</article-title>. <source>J Ginseng Res</source>. <volume>42</volume>(<issue>2</issue>):<fpage>233</fpage>&#x02013;<lpage>237</lpage>.<pub-id pub-id-type="pmid">29719472</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Son</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>SS.</given-names></name></person-group>
<year>2004</year>
<article-title>Anti-inflammatory plant flavonoids and cellular action mechanisms</article-title>. <source>J Pharmacol Sci</source>. <volume>96</volume>(<issue>3</issue>):<fpage>229</fpage>&#x02013;<lpage>245</lpage>.<pub-id pub-id-type="pmid">15539763</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kishimoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ninomiya-Tsuji</surname><given-names>J.</given-names></name></person-group>
<year>2000</year>
<article-title>TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop</article-title>. <source>J Biol Chem</source>. <volume>275</volume>(<issue>10</issue>):<fpage>7359</fpage>&#x02013;<lpage>7364</lpage>.<pub-id pub-id-type="pmid">10702308</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koeberle</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Werz</surname><given-names>O.</given-names></name></person-group>
<year>2014</year>
<article-title>Multi-target approach for natural products in inflammation</article-title>. <source>Drug Discov Today</source>. <volume>19</volume>(<issue>12</issue>):<fpage>1871</fpage>&#x02013;<lpage>1882</lpage>.<pub-id pub-id-type="pmid">25172801</pub-id></mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tiwari</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name></person-group>
<year>2018</year>
<article-title>Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of Alzheimer disease: an important role of <italic>in silico</italic> methods in multi-target directed ligands design</article-title>. <source>Curr Neuropharmacol</source>. <volume>16</volume>(<issue>6</issue>):<fpage>726</fpage>&#x02013;<lpage>739</lpage>.<pub-id pub-id-type="pmid">29542413</pub-id></mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuttinath</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rammohan</surname><given-names>R.</given-names></name></person-group>
<year>2019</year>
<article-title>Phytochemical screening, antioxidant, antimicrobial, and antibiofilm activity of <italic>Sauropus androgynus</italic> leaf extracts</article-title>. <source>Asian J Pharm Clin Res</source>. <volume>12</volume>:<fpage>244</fpage>&#x02013;<lpage>250</lpage>.</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Moon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>JL.</given-names></name></person-group>
<year>2007</year>
<article-title>Src tyrosine kinases mediate activations of NF-kappaB and integrin signal during lipopolysaccharide-induced acute lung injury</article-title>. <source>J Immunol</source>. <volume>179</volume>(<issue>10</issue>):<fpage>7001</fpage>&#x02013;<lpage>7011</lpage>.<pub-id pub-id-type="pmid">17982091</pub-id></mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hossain</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2019</year>
<article-title>Compound K, a ginsenoside metabolite, plays an antiinflammatory role in macrophages by targeting the AKT1-mediated signaling pathway</article-title>. <source>J Ginseng Res</source>. <volume>43</volume>(<issue>1</issue>):<fpage>154</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="pmid">30662304</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Padzil</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Syahida</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Abdullah</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zuhainis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Maziah</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sulaiman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Israf</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shaari</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lajis</surname><given-names>N.</given-names></name></person-group>
<year>2011</year>
<article-title>Evaluation of anti-inflammatory, antioxidant and anti-nociceptive activities of six Malaysian medicinal plants</article-title>. <source>J Med Plant Res</source>. <volume>5</volume>:<fpage>5555</fpage>&#x02013;<lpage>5563</lpage>.</mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Strelow</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fontana</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Wesche</surname><given-names>H.</given-names></name></person-group>
<year>2002</year>
<article-title>IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase</article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>99</volume>(<issue>8</issue>):<fpage>5567</fpage>&#x02013;<lpage>5572</lpage>.<pub-id pub-id-type="pmid">11960013</pub-id></mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Tupper</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Bannerman</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Winn</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Harlan</surname><given-names>JM.</given-names></name></person-group>
<year>2003</year>
<article-title>Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells</article-title>. <source>Infect Immun</source>. <volume>71</volume>(<issue>8</issue>):<fpage>4414</fpage>&#x02013;<lpage>4420</lpage>.<pub-id pub-id-type="pmid">12874320</pub-id></mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name></person-group>
<year>2017</year>
<article-title>The tyrosine kinase Src promotes phosphorylation of the kinase TBK1 to facilitate type I interferon production after viral infection</article-title>. <source>Sci Signal</source>. <volume>10</volume>(<issue>460</issue>):<fpage>eaae0435</fpage>.<pub-id pub-id-type="pmid">28049762</pub-id></mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lirk</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rieder</surname><given-names>J.</given-names></name></person-group>
<year>2002</year>
<article-title>Inducible nitric oxide synthase-time for reappraisal</article-title>. <source>Curr Drug Targets Inflamm Allergy</source>. <volume>1</volume>(<issue>1</issue>):<fpage>89</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">14561209</pub-id></mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hyun</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>KZQ</given-names></name>, <name name-style="western"><surname>Cates</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Perkins</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bannerman</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Puch&#x000e9;</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Toshchakov</surname><given-names>VY</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2012</year>
<article-title>TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia</article-title>. <source>J Biol Chem</source>. <volume>287</volume>(<issue>20</issue>):<fpage>16132</fpage>&#x02013;<lpage>16145</lpage>.<pub-id pub-id-type="pmid">22447928</pub-id></mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2018</year>
<article-title>LPS-induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF-&#x003ba;B, STAT3 or AP-1 activation</article-title>. <source>Mol Med Rep</source>. <volume>17</volume>(<issue>4</issue>):<fpage>5484</fpage>&#x02013;<lpage>5491</lpage>.<pub-id pub-id-type="pmid">29393460</pub-id></mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowell</surname><given-names>CA.</given-names></name></person-group>
<year>2011</year>
<article-title>Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <volume>3</volume>(<issue>3</issue>):<fpage>a002352</fpage>.<pub-id pub-id-type="pmid">21068150</pub-id></mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madhu</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Manukumar</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Basavaraju</surname><given-names>P.</given-names></name></person-group>
<year>2014</year>
<article-title>New-vista in finding antioxidant and anti-inflammatory property of crude protein extract from <italic>Sauropus androgynus</italic> leaf</article-title>. <source>Acta Sci Pol Technol Aliment</source>. <volume>13</volume>(<issue>4</issue>):<fpage>375</fpage>&#x02013;<lpage>383</lpage>.<pub-id pub-id-type="pmid">28067479</pub-id></mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medina-Franco</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Giulianotti</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Welmaker</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Houghten</surname><given-names>RA.</given-names></name></person-group>
<year>2013</year>
<article-title>Shifting from the single to the multitarget paradigm in drug discovery</article-title>. <source>Drug Discov Today</source>. <volume>18</volume>(<issue>9&#x02013;10</issue>):<fpage>495</fpage>&#x02013;<lpage>501</lpage>.<pub-id pub-id-type="pmid">23340113</pub-id></mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nijveldt</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Van Nood</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Van Hoorn</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Boelens</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Van Norren</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Van Leeuwen</surname><given-names>PA.</given-names></name></person-group>
<year>2001</year>
<article-title>Flavonoids: a review of probable mechanisms of action and potential applications</article-title>. <source>Am J Clin Nutr</source>. <volume>74</volume>(<issue>4</issue>):<fpage>418</fpage>&#x02013;<lpage>425</lpage>.<pub-id pub-id-type="pmid">11566638</pub-id></mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>TY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Sim</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Baik</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Hahm</surname><given-names>KB.</given-names></name></person-group>
<year>2008</year>
<article-title><italic>Artemisia asiatica</italic> extracts protect against ethanol-induced injury in gastric mucosa of rats</article-title>. <source>J Gastroenterol Hepatol</source>. <volume>23</volume>(<issue>6</issue>):<fpage>976</fpage>&#x02013;<lpage>984</lpage>.<pub-id pub-id-type="pmid">18444990</pub-id></mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roifman</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Eisenberg</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Genest</surname><given-names>J.</given-names></name></person-group>
<year>2011</year>
<article-title>Chronic inflammatory diseases and cardiovascular risk: a systematic review</article-title>. <source>Can J Cardiol</source>. <volume>27</volume>(<issue>2</issue>):<fpage>174</fpage>&#x02013;<lpage>182</lpage>.<pub-id pub-id-type="pmid">21459266</pub-id></mixed-citation></ref><ref id="CIT0047"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romanova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vachalkova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cipak</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ovesna</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Rauko</surname><given-names>P.</given-names></name></person-group>
<year>2001</year>
<article-title>Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method</article-title>. <source>Neoplasma</source>. <volume>48</volume>(<issue>2</issue>):<fpage>104</fpage>&#x02013;<lpage>107</lpage>.<pub-id pub-id-type="pmid">11478688</pub-id></mixed-citation></ref><ref id="CIT0048"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabroe</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Dower</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Whyte</surname><given-names>MK.</given-names></name></person-group>
<year>2008</year>
<article-title>The role of TLR activation in inflammation</article-title>. <source>J Pathol</source>. <volume>214</volume>(<issue>2</issue>):<fpage>126</fpage>&#x02013;<lpage>135</lpage>.<pub-id pub-id-type="pmid">18161748</pub-id></mixed-citation></ref><ref id="CIT0049"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schett</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Elewaut</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McInnes</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Dayer</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Neurath</surname><given-names>MF.</given-names></name></person-group>
<year>2013</year>
<article-title>How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy</article-title>. <source>Nat Med</source>. <volume>19</volume>(<issue>7</issue>):<fpage>822</fpage>&#x02013;<lpage>824</lpage>.<pub-id pub-id-type="pmid">23836224</pub-id></mixed-citation></ref><ref id="CIT0050"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schett</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Neurath</surname><given-names>MF.</given-names></name></person-group>
<year>2018</year>
<article-title>Resolution of chronic inflammatory disease: universal and tissue-specific concepts</article-title>. <source>Nat Commun</source>. <volume>9</volume>(<issue>1</issue>):<fpage>3261</fpage>.<pub-id pub-id-type="pmid">30111884</pub-id></mixed-citation></ref><ref id="CIT0051"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selvi</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Anusha</surname><given-names>B.</given-names></name></person-group>
<year>2012</year>
<article-title>Anti-inflammatory and analgesic activities of the <italic>Sauropus androgynus</italic> (L) Merr. (Euphorbiaceae) plant in experimental animal models</article-title>. <source>Der Pharm Lett</source>. <volume>4</volume>:<fpage>782</fpage>&#x02013;<lpage>785</lpage>.</mixed-citation></ref><ref id="CIT0052"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Salim</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>R.</given-names></name></person-group>
<year>2011</year>
<article-title>Estimation of proximate composition, micronutrients and phytochemical compounds in traditional vegetables from Andaman and Nicobar Islands</article-title>. <source>Int J Food Sci Nutr</source>. <volume>62</volume>(<issue>7</issue>):<fpage>765</fpage>&#x02013;<lpage>773</lpage>.<pub-id pub-id-type="pmid">21615278</pub-id></mixed-citation></ref><ref id="CIT0053"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stratman</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Carter</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Sethy</surname><given-names>VH.</given-names></name></person-group>
<year>1997</year>
<article-title>Ibuprofen: effect on inducible nitric oxide synthase</article-title>. <source>Brain Res Mol Brain Res</source>. <volume>50</volume>(<issue>1&#x02013;2</issue>):<fpage>107</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">9406924</pub-id></mixed-citation></ref><ref id="CIT0054"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group>
<year>2010</year>
<article-title>Pattern recognition receptors and inflammation</article-title>. <source>Cell</source>. <volume>140</volume>(<issue>6</issue>):<fpage>805</fpage>&#x02013;<lpage>820</lpage>.<pub-id pub-id-type="pmid">20303872</pub-id></mixed-citation></ref><ref id="CIT0055"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanimura</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Saitoh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Akashi-Takamura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>K.</given-names></name></person-group>
<year>2008</year>
<article-title>Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling</article-title>. <source>Biochem Biophys Res Commun</source>. <volume>368</volume>(<issue>1</issue>):<fpage>94</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">18222170</pub-id></mixed-citation></ref><ref id="CIT0056"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Wendy</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Siong</surname><given-names>JYF</given-names></name>, <name name-style="western"><surname>Syamsumir</surname><given-names>DF.</given-names></name></person-group>
<year>2011</year>
<article-title>Characterization of antimicrobial, antioxidant, anticancer properties and chemical composition of <italic>Sauropus androgynus</italic> stem extract</article-title>. <source>Acta Med Lituan</source>. <volume>18</volume>(<issue>1</issue>):<fpage>12</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="CIT0057"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woerdenbag</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Kayser</surname><given-names>O.</given-names></name></person-group>
<year>2014</year>
<article-title>Jamu: Indonesian traditional herbal medicine towards rational phytopharmacological use</article-title>. <source>J Herb Med</source>. <volume>4</volume>:<fpage>51</fpage>&#x02013;<lpage>73</lpage>.</mixed-citation></ref><ref id="CIT0058"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Hyun</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HS.</given-names></name></person-group>
<year>2005</year>
<article-title>Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells</article-title>. <source>Biochem Biophys Res Commun</source>. <volume>335</volume>(<issue>4</issue>):<fpage>1017</fpage>&#x02013;<lpage>1025</lpage>.<pub-id pub-id-type="pmid">16102725</pub-id></mixed-citation></ref><ref id="CIT0059"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>L.</given-names></name></person-group>
<year>2015</year>
<article-title>Effectiveness of and risk associated with aspirin therapy in hemodialysis patients with a background of antiplatelet factor 4/heparin complex antibody detection</article-title>. <source>Thromb Res</source>. <volume>136</volume>(<issue>1</issue>):<fpage>61</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">25936230</pub-id></mixed-citation></ref><ref id="CIT0060"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2014</year>
<article-title>Novel anti-inflammatory function of NSC95397 by the suppression of multiple kinases</article-title>. <source>Biochem Pharmacol</source>. <volume>88</volume>(<issue>2</issue>):<fpage>201</fpage>&#x02013;<lpage>215</lpage>.<pub-id pub-id-type="pmid">24468133</pub-id></mixed-citation></ref><ref id="CIT0061"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name></person-group>
<year>2016</year>
<article-title><italic>Cerbera manghas</italic> methanol extract exerts anti-inflammatory activity by targeting c-Jun N-terminal kinase in the AP-1 pathway</article-title>. <source>J Ethnopharmacol</source>. <volume>193</volume>:<fpage>387</fpage>&#x02013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">27562319</pub-id></mixed-citation></ref><ref id="CIT0062"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Chin</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name></person-group>
<year>2011</year>
<article-title>Separation of anti-ulcer flavonoids from <italic>Artemisia</italic> extracts by high-speed countercurrent chromatography</article-title>. <source>Food Chem</source>. <volume>129</volume>(<issue>2</issue>):<fpage>679</fpage>&#x02013;<lpage>683</lpage>.<pub-id pub-id-type="pmid">30634286</pub-id></mixed-citation></ref><ref id="CIT0063"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zanoni</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ostuni</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Marek</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Barresi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Barbalat</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Barton</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Granucci</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kagan</surname><given-names>JC.</given-names></name></person-group>
<year>2011</year>
<article-title>CD14 controls the LPS-induced endocytosis of Toll-like receptor 4</article-title>. <source>Cell</source>. <volume>147</volume>(<issue>4</issue>):<fpage>868</fpage>&#x02013;<lpage>880</lpage>.<pub-id pub-id-type="pmid">22078883</pub-id></mixed-citation></ref><ref id="CIT0064"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>JX</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>YD</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Koike</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Akihisa</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name></person-group>
<year>2020</year>
<article-title><italic>Sauropus androgynus</italic> L. Merr.&#x02014;a phytochemical, pharmacological and toxicological review</article-title>. <source>J Ethnopharmacol</source>. <volume>257</volume>:<fpage>112778</fpage>.<pub-id pub-id-type="pmid">32205260</pub-id></mixed-citation></ref><ref id="CIT0065"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Swarts</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Swarts</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2011</year>
<article-title>Antioxidant properties of quercetin</article-title>. <source>Adv Exp Med Biol</source>. <volume>701</volume>:<fpage>283</fpage>&#x02013;<lpage>289</lpage>.<pub-id pub-id-type="pmid">21445799</pub-id></mixed-citation></ref><ref id="CIT0066"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name></person-group>
<year>2017</year>
<article-title>Optimization of extraction conditions and antioxidant activities of polyphenols from <italic>Sauropus rostratu</italic>s Miq</article-title>. <source>J Henan Agric Sci</source>. <volume>31</volume>:<fpage>148</fpage>&#x02013;<lpage>152</lpage>.</mixed-citation></ref><ref id="CIT0067"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name></person-group>
<year>2013</year>
<article-title>Anti-inflammatory and analgesic effect of S<italic>auropus rostratus</italic></article-title>. <source>Chin J Exp Tradit Med Form</source>. <volume>19</volume>:<fpage>270</fpage>&#x02013;<lpage>273</lpage>.</mixed-citation></ref></ref-list></back></article>